Cancer patients receiving immune checkpoint inhibitor (ICI) therapy may experience more severe toxicity and have a greater risk of death if they have recently used proton pump inhibitors (PPIs), ...

Finding seen for patients with chronic lymphocytic leukemia receiving immunoglobulin replacement therapy regularly.

A quality improvement project incorporated 4 interventions to improve the rate of CLABSIs in pediatric hematology/oncology/bone marrow transplantation patients.

CRS is a life-threatening condition that results in the excessive release of cytokines into the bloodstream, causing inflammation and damage to organs and tissues.

Adjuvant chemoradiation combined with camrelizumab was well tolerated and yielded significantly improved long-term survival,” the researchers wrote.